5342 Nucleic Acids Research, 2009, Vol. 37, No. 16 16. Lee,S.H., Girard,S., Macina,D., Busa,M., Zafer,A., Belouchi,A., Gros,P. and Vidal,S.M. (2001) Susceptibility to mouse cytomega- lovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat. Genet., 28, 42–45. 17. Daniels,K.A., Devora,G., Lai,W.C., O’Donnell,C.L., Bennett,M. and Welsh,R.M. (2001) Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J. Exp. Med., 194, 29–44. 18. Takei,F., McQueen,K.L., Maeda,M., Wilhelm,B.T., Lohwasser,S., Lian,R.H. and Mager,D.L. (2001) Ly49 and CD94/NKG2: developmentally regulated expression and evolution. Immunol. Rev., 181, 90–103. 19. Saleh,A., Makrigiannis,A.P., Hodge,D.L. and Anderson,S.K. (2002) Identiﬁcation of a novel Ly49 promoter that is active in bone marrow and fetal thymus. J. Immunol., 168, 5163–5169. 20. Saleh,A., Davies,G.E., Pascal,V., Wright,P.W., Hodge,D.L., Cho,E.H., Lockett,S.J., Abshari,M. and Anderson,S.K. (2004) Identiﬁcation of probabilistic transcriptional switches in the Ly49 gene cluster: a eukaryotic mechanism for selective gene activation. Immunity, 21, 55–66. 21. Smith,H.R., Chuang,H.H., Wang,L.L., Salcedo,M., Heusel,J.W. and Yokoyama,W.M. (2000) Nonstochastic coexpression of activation receptors on murine natural killer cells. J. Exp. Med., 191, 1341–1354. 22. Rouhi,A., Gagnier,L., Takei,F. and Mager,D.L. (2006) Evidence for epigenetic maintenance of Ly49A monoallelic gene expression. J. Immunol., 176, 2991–2999. 23. Cheng,T.P., French,A.R., Plougastel,B.F., Pingel,J.T., Orihuela,M.M., Buller,M.L. and Yokoyama,W.M. (2008) Ly49h is necessary for genetic resistance to murine cytomegalovirus. Immunogenetics, 60, 565–573. 24. Takei,F., Brennan,J. and Mager,D.L. (1997) The Ly-49 family: genes, proteins and recognition of class I MHC. Immunol. Rev., 155, 67–77. 25. Brennan,J., Lemieux,S., Freeman,J.D., Mager,D.L. and Takei,F. (1996) Heterogeneity among Ly-49C natural killer (NK) cells: characterization of highly related receptors with diﬀering functions and expression patterns. J. Exp. Med., 184, 2085–2090. 26. Maksakova,I.A. and Mager,D.L. (2005) Transcriptional regulation of early transposon elements, an active family of mouse long terminal repeat retrotransposons. J. Virol., 79, 13865–13874. 27. Kubota,A., Kubota,S., Lohwasser,S., Mager,D.L. and Takei,F. (1999) Diversity of NK cell receptor repertoire in adult and neonatal mice. J. Immunol., 163, 212–216. 28. Landry,J.R., Rouhi,A., Medstrand,P. and Mager,D.L. (2002) The Opitz syndrome gene Mid1 is transcribed from a human endogenous retroviral promoter. Mol. Biol. Evol., 19, 1934–1942. 29. Coles,M.C., McMahon,C.W., Takizawa,H. and Raulet,D.H. (2000) Memory CD8 T lymphocytes express inhibitory MHC-speciﬁc Ly49 receptors. Eur. J. Immunol., 30, 236–244. 30. Assarsson,E., Kambayashi,T., Sandberg,J.K., Hong,S., Taniguchi,M., Van Kaer,L., Ljunggren,H.G. and Chambers,B.J. (2000) CD8+ T cells rapidly acquire NK1.1 and NK cell-associated molecules upon stimulation in vitro and in vivo. J. Immunol., 165, 3673–3679. 31. Bakker,A.B., Hoek,R.M., Cerwenka,A., Blom,B., Lucian,L., McNeil,T., Murray,R., Phillips,L.H., Sedgwick,J.D. and Lanier,L.L. (2000) DAP12-deﬁcient mice fail to develop autoim- munity due to impaired antigen priming. Immunity, 13, 345–353. 32. Voyle,R.B., Beermann,F., Lees,R.K., Schumann,J., Zimmer,J., Held,W. and MacDonald,H.R. (2003) Ligand-dependent inhibition of CD1d-restricted NKT cell development in mice transgenic for the activating receptor Ly49D. J. Exp. Med., 197, 919–925. 33. Ortaldo,J.R., Winkler-Pickett,R., Willette-Brown,J., Wange,R.L., Anderson,S.K., Palumbo,G.J., Mason,L.H. and McVicar,D.W. (1999) Structure/function relationship of activating Ly-49D and inhibitory Ly-49G2 NK receptors. J. Immunol., 163, 5269–5277. 34. Tassi,I., Le Friec,G., Gilﬁllan,S., Takai,T., Yokoyama,W.M. and Colonna,M. (2009) DAP10 associates with Ly49 receptors but contributes minimally to their expression and function in vivo. Eur. J. Immunol., 39, 1129–1135. 35. Wilhelm,B.T., McQueen,K.L., Freeman,J.D., Takei,F. and Mager,D.L. (2001) Comparative analysis of the promoter regions and transcriptional start sites of mouse Ly49 genes. Immunogenetics, 53, 215–224. 36. Makrigiannis,A.P., Pau,A.T., Saleh,A., Winkler-Pickett,R., Ortaldo,J.R. and Anderson,S.K. (2001) Class I MHC-binding characteristics of the 129/J Ly49 repertoire. J. Immunol., 166, 5034–5043. 37. Makrigiannis,A.P., Pau,A.T., Schwartzberg,P.L., McVicar,D.W., Beck,T.W. and Anderson,S.K. (2002) A BAC contig map of the Ly49 gene cluster in 129 mice reveals extensive diﬀerences in gene content relative to C57BL/6 mice. Genomics, 79, 437–444. 38. Silver,E.T., Gong,D.E., Chang,C.S., Amrani,A., Santamaria,P. and Kane,K.P. (2000) Ly-49P activates NK-mediated lysis by recogniz- ing H-2Dd. J. Immunol., 165, 1771–1781. 39. Rhoades,K.L., Singh,N., Simon,I., Glidden,B., Cedar,H. and Chess,A. (2000) Allele-speciﬁc expression patterns of interleukin-2 and Pax-5 revealed by a sensitive single-cell RT-PCR analysis. Curr. Biol., 10, 789–792. 40. Jamieson,A.M., Diefenbach,A., McMahon,C.W., Xiong,N., Carlyle,J.R. and Raulet,D.H. (2002) The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity, 17, 19–29. 41. Makrigiannis,A.P., Rousselle,E. and Anderson,S.K. (2004) Independent control of Ly49g alleles: implications for NK cell repertoire selection and tumor cell killing. J. Immunol., 172, 1414–1425. 42. Held,W. and Kunz,B. (1998) An allele-speciﬁc, stochastic gene expression process controls the expression of multiple Ly49 family genes and generates a diverse, MHC-speciﬁc NK cell receptor repertoire. Eur. J. Immunol., 28, 2407–2416. 43. Fodil-Cornu,N., Lee,S.H., Belanger,S., Makrigiannis,A.P., Biron,C.A., Buller,R.M. and Vidal,S.M. (2008) Ly49h-deﬁcient C57BL/6 mice: a new mouse cytomegalovirus-susceptible model remains resistant to unrelated pathogens controlled by the NK gene complex. J. Immunol., 181, 6394–6405. 44. Rogers,S.L., Rouhi,A., Takei,F. and Mager,D.L. (2006) A role for DNA hypomethylation and histone acetylation in maintaining allele-speciﬁc expression of mouse NKG2A in developing and mature NK cells. J. Immunol., 177, 414–421. 45. Xu,J., Vallejo,A.N., Jiang,Y., Weyand,C.M. and Goronzy,J.J. (2005) Distinct transcriptional control mechanisms of killer immunoglobulin-like receptors in natural killer (NK) and in T cells. J. Biol. Chem., 280, 24277–24285. 46. Shi,Y., Lee,J.S. and Galvin,K.M. (1997) Everything you have ever wanted to know about Yin Yang 1. Biochim. Biophys. Acta, 1332, F49–F66. 47. Rouhi,A., Brooks,C.G., Takei,F. and Mager,D.L. (2007) Plasticity of Ly49g expression is due to epigenetics. Mol. Immunol., 44, 821–826. 48. Lee,S.H., Zafer,A., de Repentigny,Y., Kothary,R., Tremblay,M.L., Gros,P., Duplay,P., Webb,J.R. and Vidal,S.M. (2003) Transgenic expression of the activating natural killer receptor Ly49H confers resistance to cytomegalovirus in genetically susceptible mice. J. Exp. Med., 197, 515–526. 49. Merck,E., Voyle,R.B. and MacDonald,H.R. (2009) Ly49D engagement on T lymphocytes induces TCR-independent activation and CD8 eﬀector functions that control tumor growth. J. Immunol., 182, 183–192. 50. Tanamachi,D.M., Moniot,D.C., Cado,D., Liu,S.D., Hsia,J.K. and Raulet,D.H. (2004) Genomic Ly49A transgenes: basis of variegated Ly49A gene expression and identiﬁcation of a critical regulatory element. J. Immunol., 172, 1074–1082. 51. Abi-Rached,L. and Parham,P. (2005) Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues. J. Exp. Med., 201, 1319–1332.